recent articles
Hørsholm, Denmark -- Today, the Market Development Fund, announced that it will support Visiopharm’s validation of its novel solutions for cancer diagnostics at seven Danish Hospitals and three international Hospitals. Visiopharm’s...
© 2023 Tissuepathology.com. All rights reserved. Millennial Consulting. | Web Design by Zealth Digital Marketing